

<!-- ```{r abbreviations,  echo=FALSE, warning=TRUE} -->
<!-- abbreviations <- read_xlsx("figure/Abbreviations/Abbreviations.xlsx") -->
<!-- abbreviations <- abbreviations[order(abbreviations$Abbreviation),] -->

<!-- abbreviations %>% kable(abbreviations, booktabs = T, longtable = T,  -->
<!--                         format = "latex", escape = F, caption = "Full list of abbreviations") #%>% -->
<!-- ``` -->


\begin{longtable}[t]{ll}
\caption{Full list of abbreviations}\\
\toprule
Abbreviation & Full name\\
\midrule
ACD & Acid citrate dextrose\\
ACTB & Actin\\
ADH & Alcohol dehydrogenase\\
ADH4 & Alcohol dehydrogenase 4\\
ADP & Adenosine diphosphate\\
\addlinespace
APMAP & Adipocyte plasma membrane-associated protein\\
AU & Arbitrary Units\\
AUC & Area under the curve\\
BAT & Brown adipose tissue\\
BCA & Bicinchoninic acid\\
\addlinespace
BMI & Body mass index\\
BSA & Bovine serum albumin\\
CAD & Coronary artery disease\\
CBPM & Carboxypeptidase M\\
CCR4 & C-C motif chemokine receptor 4\\
\addlinespace
CHAD & Chondroadherin\\
CHD & Coronary heart disease\\
CRP & C-reactive protein/collagen-related peptide\\
DAPT & Dual antiplatelet therapy\\
DAVID & Database for annotation, visualization and integrated discovery\\
\addlinespace
DiRECT & Diabetes REmission Clinical Trial\\
DTT & Dithiothreitol\\
DVT & Deep vein thrombosis\\
DXA & Dual-energy X-ray Absorptiometry\\
EC50 & Half maximal effective concentration\\
\addlinespace
EDTA & Ethylenediamine tetraacetic acid\\
ELISA & Enzyme-linked immunosorbent assay\\
ERK & Extracellular signal regulated kinase\\
FAAA & Fumarylacetoacetase\\
FABP & Fatty acid binding protein\\
\addlinespace
FABP & Fatty acid binding protein\\
FDR & False discovery rate\\
FHS & Framingham Heart Study\\
FSC & Forward scatter\\
GAD & Genetic association database\\
\addlinespace
GAM & Generalized additive model\\
GHR & Growth hormone receptor\\
GIANT & Genetic Investigation of Anthromopetric Traits\\
GLSMR & GAM and linear stratified Mendelian randomisation\\
GO & Gene ontology\\
\addlinespace
GP & Glycoprotein\\
GPCR & G protein coupled receptor\\
GRK6 & G protein-coupled receptor kinase 6\\
GRS & Genetic risk score\\
GWAS & Genome wide association study\\
\addlinespace
H-IPF & High fluorescence immature platelet fraction\\
HbA1c & Glycated haemoglobin\\
HDL & High density lipoprotein\\
IGF-1 & Insulin-like growth factor 1\\
IGFBP & Insulin-like growth factor binding protein\\
\addlinespace
IHD & Ischaemic heart disease\\
IL-6 & Interleukin-6\\
IL6R & Interleukin-6 receptor\\
INHBC & Inhibin Î² C chain\\
IP3 & Inositol trisphosphate\\
\addlinespace
IPC & Immature platelet count\\
IPF & Immature platelet fraction\\
IQR & Interquartile range\\
IRAS & Integrated Research Application System\\
IVW & Inverse variance weighted\\
\addlinespace
LACE & Localised average causal effect\\
LDL & Low density lipoprotein\\
LTA & Light transmittance aggregometry\\
MACE & Major adverse cardiovascular event\\
MAPK & Mitogen-activated protein kinase\\
\addlinespace
MDC & Macrophage derived chemokie\\
MEA & Multiple electrode aggregometry\\
MFI & Median fluorescence intensity\\
MMP-2 & Metalloproteinase-2\\
MPO & Myeloperoxidase\\
\addlinespace
MPV & Mean platelet volume\\
MR & Mendelian randomization\\
MS & Mass spectrometry\\
MS & Metabolic syndrome\\
NHSBT & NHS Blood and Transplant\\
\addlinespace
NHSBT & National Health Service Blood and Transplant\\
NLMR & Nonlinear Mendelian randomisation\\
NO & Nitric oxide\\
NSAID & Non-steroidal anti-inflammatory drug\\
OLS & Ordinary least squares\\
\addlinespace
P-LCR & Platelet large cell ratio\\
PAFAH & Platelet-activating factor acetylhydrolase\\
PAR-1 & Protease-activated receptor 1\\
PAR1-AP/TRAP-6 & PAR1-activating peptide\\
PBS & Phoshate-buffered saline\\
\addlinespace
PCA & Principal component analysis\\
PCI & Percutaneous coronary intervention\\
PCT & Plateletcrit\\
PDGF & Platelet-derived growth factor\\
PDVF & Poly(vinylidene fluoride)\\
\addlinespace
PDW & Platelet distribution width\\
PE & Pulmonary embolism\\
PEAR1 & Platelet endothelial aggregation receptor 1\\
pEC50 & The negative logarithm of the EC50\\
PECAM-1 & Platelet endothelial cell adhesion molecule-1\\
\addlinespace
PFA & Paraformaldehyde\\
PGE1 & Prostaglandin E1\\
PGI2 & Prostaglandin I2\\
PI3K & Phosphoinositde-3-kinase\\
PKA & Protien kinase A\\
\addlinespace
PKB & Protein kinase B\\
PKC & Protein kinase C\\
PLC & Phospholipase C\\
PLT (F) & Platelet count (PLT-F channel)\\
PLT (I) & Platelet count (impedance channel)\\
\addlinespace
PPP & Platelet poor plasma\\
pQTL & Protein quantitative trait loci\\
PROTACs & Proteolysis targeting chimeras\\
PRP & Platelet rich plasma\\
PS & Phosphatidylserine\\
\addlinespace
PSGL-1 & P-selectin glycoprotein ligand-1\\
PTPRU & Receptor-type tyrosine-protein phosphatase U\\
QC & Quality control\\
RCT & Randomised control trial\\
RFU & Relative fluorescent units\\
\addlinespace
RIPA & Radioimmunoprecipitation assay\\
ROCK & Rho-associated protein kinase\\
RPM & Revolutions per minute\\
S100A9/MRP-14 & Myeloid-related protein-14\\
SCAR5 & Scavenger receptor class A member 5\\
\addlinespace
SD & Standard deviation\\
SDS & Sodium dodecyl sulphate\\
SEM & Standard error of the mean\\
SFL & Side fluorescence\\
SHBG & Sex hormone binding globulin\\
\addlinespace
SNP & Single nucleotide polymorphism\\
SOMAmer & Slow Off-rate Modified Aptamers\\
SSC & Side scatter\\
T2D & Type 2 Diabetes mellitus\\
TARC & Thymus and activation regulated chemokine\\
\addlinespace
TBS & Tris buffered saline\\
TEMED & Tetramethylethylenediamine\\
TLS & Total least squares\\
TMT-MS & Tandem mass tag mass spectrometry\\
TNF-alpha & Tumour necrosis factor-alpha\\
\addlinespace
TPO & Thrombopoietin\\
TSLS/2SLS & Two stage least squares\\
TxA2 & Thromboxane A2\\
VASP & Vasodilator-stimulator phosphoprotein\\
VLED & Very low energy diet\\
\addlinespace
VTE & Venous thromboembolism\\
WAT & White adipose tissue\\
WHRadjBMI & Waist-hip ratio adjusted for BMI\\
\bottomrule
\end{longtable}
